IL130291A0 - Compositions and methods for administering pneumococcal DNA - Google Patents
Compositions and methods for administering pneumococcal DNAInfo
- Publication number
- IL130291A0 IL130291A0 IL13029197A IL13029197A IL130291A0 IL 130291 A0 IL130291 A0 IL 130291A0 IL 13029197 A IL13029197 A IL 13029197A IL 13029197 A IL13029197 A IL 13029197A IL 130291 A0 IL130291 A0 IL 130291A0
- Authority
- IL
- Israel
- Prior art keywords
- administering
- compositions
- methods
- pneumococcal dna
- pneumococcal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75950596A | 1996-12-04 | 1996-12-04 | |
PCT/US1997/022847 WO1998024927A1 (en) | 1996-12-04 | 1997-12-04 | Compositions and methods for administering pneumococcal dna |
Publications (1)
Publication Number | Publication Date |
---|---|
IL130291A0 true IL130291A0 (en) | 2000-06-01 |
Family
ID=25055905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13029197A IL130291A0 (en) | 1996-12-04 | 1997-12-04 | Compositions and methods for administering pneumococcal DNA |
Country Status (9)
Country | Link |
---|---|
US (1) | US20020102242A1 (de) |
EP (1) | EP1019522A4 (de) |
JP (1) | JP2002514061A (de) |
AU (1) | AU5523798A (de) |
CA (1) | CA2274095A1 (de) |
IL (1) | IL130291A0 (de) |
NO (1) | NO992665L (de) |
WO (1) | WO1998024927A1 (de) |
ZA (1) | ZA9710934B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002362447A1 (en) * | 2001-10-03 | 2003-04-14 | University Of Rochester | Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
US20120135037A1 (en) | 2009-06-01 | 2012-05-31 | Mizel Steven B | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
IN2014CN04332A (de) | 2011-12-14 | 2015-09-04 | Ineos Europe Ag | |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476929A (en) * | 1991-02-15 | 1995-12-19 | Uab Research Foundation | Structural gene of pneumococcal protein |
DK0571538T5 (da) * | 1991-02-15 | 2002-03-04 | Uab Research Foundation | Strukturgen for pneumokokprotein |
-
1997
- 1997-12-04 AU AU55237/98A patent/AU5523798A/en not_active Abandoned
- 1997-12-04 JP JP52589598A patent/JP2002514061A/ja active Pending
- 1997-12-04 WO PCT/US1997/022847 patent/WO1998024927A1/en not_active Application Discontinuation
- 1997-12-04 CA CA002274095A patent/CA2274095A1/en not_active Abandoned
- 1997-12-04 EP EP97951660A patent/EP1019522A4/de not_active Withdrawn
- 1997-12-04 IL IL13029197A patent/IL130291A0/xx unknown
- 1997-12-04 ZA ZA9710934A patent/ZA9710934B/xx unknown
-
1999
- 1999-06-02 NO NO992665A patent/NO992665L/no not_active Application Discontinuation
-
2001
- 2001-04-27 US US09/844,645 patent/US20020102242A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO992665L (no) | 1999-08-04 |
US20020102242A1 (en) | 2002-08-01 |
AU5523798A (en) | 1998-06-29 |
EP1019522A4 (de) | 2002-06-19 |
NO992665D0 (no) | 1999-06-02 |
WO1998024927A1 (en) | 1998-06-11 |
ZA9710934B (en) | 1998-09-10 |
CA2274095A1 (en) | 1998-06-11 |
EP1019522A1 (de) | 2000-07-19 |
JP2002514061A (ja) | 2002-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL127545A0 (en) | Compositions and methods for administering borrelia DNA | |
GB2331015B (en) | Therapeutic methods and compositions involving isoflavones | |
ZA978868B (en) | Vaccine composition | |
GB9616411D0 (en) | Shampoo compositions and method | |
AP9801369A0 (en) | Dispersible macromole-cule compositions and methods for their preparation and use | |
EP0939640A4 (de) | Verbesserungen bei polymerzusammensetzungen zur chemotherapie sowie behandlungsverfahren unter deren verwendung | |
EP0943327A4 (de) | Arzneimittel | |
ZA968322B (en) | Solid sillicone compositions and methods for their preparation and use | |
GB9619761D0 (en) | Shampoo composition | |
GB9616351D0 (en) | Vaccine composition | |
GB9623233D0 (en) | Vaccine composition | |
IL111554A (en) | Methods and compositions for hair treatment | |
EP0890599A4 (de) | Polyorganosiloxane und verfahren zu deren herstellung | |
IL130291A0 (en) | Compositions and methods for administering pneumococcal DNA | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
AU1829097A (en) | Methods for regenerating scarless skin and compositions used therein | |
EP0987942A4 (de) | Pharmazeutische zusammensetzung und verfahren zu ihrer verwendung | |
GB9606579D0 (en) | Pharmaceutical composition and methods for the manufacture thereof | |
GB9617346D0 (en) | Therapeutic methods and compositions for use therein | |
GB9603471D0 (en) | Therapeutic methods and compositions for use therein | |
ZA955409B (en) | Keratolytic-wound healing compositions and methods for preparing and using same | |
GB9604426D0 (en) | Pharmaceutical composition and use thereof | |
GB9620592D0 (en) | Pharmaceutical compositions and their use | |
GB9622437D0 (en) | Vaccine composition | |
GB9622438D0 (en) | Vaccine composition |